{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:22:07Z","timestamp":1794543727768,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2019.056.1"],"award-info":[{"award-number":["2019.056.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2019.056.1"],"award-info":[{"award-number":["2019.056.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2019.056.1"],"award-info":[{"award-number":["2019.056.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma of B-cell origin with frequent expression of functional B-cell receptors (BCRs). Here we report that expression cloning followed by antigen screening identifies DNA-directed RNA polymerase beta\u2019 (RpoC) from<jats:italic>Moraxella catarrhalis<\/jats:italic>as frequent antigen of BCRs of IgD<jats:sup>+<\/jats:sup>LP cells. Patients show predominance of HLA-DRB1*04\/07 and the IgVH genes encode extraordinarily long CDR3s. High-titer, light-chain-restricted anti-RpoC IgG1\/\u03ba-type serum-antibodies are additionally found in these patients. RpoC and MID\/hag, a superantigen co-expressed by<jats:italic>Moraxella catarrhalis<\/jats:italic>that is known to activate IgD<jats:sup>+<\/jats:sup>B cells by binding to the Fc domain of IgD, have additive activation effects on the BCR, the NF-\u03baB pathway and the proliferation of IgD<jats:sup>+<\/jats:sup>DEV cells expressing RpoC-specific BCRs. This suggests an additive antigenic and superantigenic stimulation of B cells with RpoC-specific IgD<jats:sup>+<\/jats:sup>BCRs under conditions of a permissive MHC-II haplotype as\u00a0a model of NLPHL lymphomagenesis, implying future treatment strategies.<\/jats:p>","DOI":"10.1038\/s41467-020-16375-6","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T10:02:50Z","timestamp":1589796170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8167-2989","authenticated-orcid":false,"given":"Lorenz","family":"Thurner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Fadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi","family":"Regitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kemele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer Maria","family":"Bohle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nimmesgern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"von M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkhard A. J.","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Weniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Vornanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Eichenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6691-7191","authenticated-orcid":false,"given":"Ralf","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Dieter","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Leo","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pfreundschuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"16375_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1200\/JCO.2012.43.5958","volume":"31","author":"S Saarinen","year":"2013","unstructured":"Saarinen, S. et al. High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J. Clin. Oncol. 31, 938\u2013943 (2013).","journal-title":"J. Clin. Oncol."},{"key":"16375_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/01.pas.0000194741.87798.45","volume":"30","author":"S Prakash","year":"2006","unstructured":"Prakash, S., Fountaine, T., Raffeld, M., Jaffe, E. S. & Pittaluga, S. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am. J. Surg. Pathol. 30, 585\u2013592 (2006).","journal-title":"Am. J. Surg. Pathol."},{"key":"16375_CR3","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1084\/jem.20080809","volume":"205","author":"V Brune","year":"2008","unstructured":"Brune, V. et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J. Exp. Med. 205, 2251\u20132268 (2008).","journal-title":"J. Exp. Med."},{"key":"16375_CR4","doi-asserted-by":"publisher","first-page":"e78812","DOI":"10.1371\/journal.pone.0078812","volume":"8","author":"S Hartmann","year":"2013","unstructured":"Hartmann, S. et al. Nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma\u2014endpoints of a spectrum of one disease? PLoS ONE 8, e78812 (2013).","journal-title":"PLoS ONE"},{"key":"16375_CR5","first-page":"2278","volume":"40","author":"S Hartmann","year":"2015","unstructured":"Hartmann, S. et al. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 40, 2278\u20132285 (2015).","journal-title":"Leukemia"},{"key":"16375_CR6","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM199803123381113","volume":"338","author":"R K\u00fcppers","year":"1998","unstructured":"K\u00fcppers, R., Rajewsky, K., Braeuninger, A. & Hansmann, M. L. L&H cells in lymphocyte-predominant Hodgkin\u2019s disease. N. Engl. J. Med. 338, 763\u2013764 (1998).","journal-title":"N. Engl. J. Med."},{"key":"16375_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJM199708143370703","volume":"337","author":"T Marafioti","year":"1997","unstructured":"Marafioti, T. et al. Origin of nodular lymphocyte-predominant Hodgkin\u2019s disease from a clonal expansion of highly mutated germinal-center B cells. N. Engl. J. Med. 337, 453\u2013458 (1997).","journal-title":"N. Engl. J. Med."},{"key":"16375_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood-2002-05-1592","volume":"101","author":"I Wlodarska","year":"2003","unstructured":"Wlodarska, I. et al. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 101, 706\u2013710 (2003).","journal-title":"Blood"},{"key":"16375_CR9","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","volume":"110","author":"A Mottok","year":"2007","unstructured":"Mottok, A., Renn\u00e9, C., Willenbrock, K., Hansmann, M. L. & Br\u00e4uninger, A. Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood 110, 3387\u20133390 (2007).","journal-title":"Blood"},{"key":"16375_CR10","doi-asserted-by":"publisher","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","volume":"94","author":"A Braeuninger","year":"1997","unstructured":"Braeuninger, A. et al. Hodgkin and Reed\u2013Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc. Natl Acad. Sci. USA 94, 9337\u20139342 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16375_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1182\/blood.V87.2.465.bloodjournal872465","volume":"87","author":"B Falini","year":"1996","unstructured":"Falini, B. et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin\u2019s disease. Blood 87, 465\u2013471 (1996).","journal-title":"Blood"},{"key":"16375_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/path.1746","volume":"205","author":"A Greiner","year":"2005","unstructured":"Greiner, A. et al. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. J. Pathol. 205, 541\u2013547 (2005).","journal-title":"J. Pathol."},{"key":"16375_CR13","doi-asserted-by":"publisher","first-page":"18470","DOI":"10.1074\/jbc.274.26.18470","volume":"274","author":"M Muramatsu","year":"1999","unstructured":"Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470\u201318476 (1999).","journal-title":"J. Biol. Chem."},{"key":"16375_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3324\/haematol.2009.010157","volume":"95","author":"MA Schumacher","year":"2010","unstructured":"Schumacher, M. A. et al. Mutations in the genes coding for the NF-kappaB regulating factors IkappaBalpha and A20 are uncommon in nodular lymphocyte-predominant Hodgkin\u2019s lymphoma. Haematologica 95, 153\u2013157 (2010).","journal-title":"Haematologica"},{"key":"16375_CR15","first-page":"1889","volume":"96","author":"I Anagnostopoulos","year":"2000","unstructured":"Anagnostopoulos, I. et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96, 1889\u20131899 (2000).","journal-title":"Blood"},{"key":"16375_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1462-5822.2010.01546.x","volume":"13","author":"V Schaar","year":"2011","unstructured":"Schaar, V. et al. Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells. Cell. Microbiol. 13, 432\u2013449 (2011).","journal-title":"Cell. Microbiol."},{"key":"16375_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.micinf.2007.12.015","volume":"10","author":"T Hallstrom","year":"2008","unstructured":"Hallstrom, T. et al. The Moraxella IgD-binding protein MID\/Hag is an oligomeric autotransporter. Microbes Infect. 10, 374\u2013381 (2008).","journal-title":"Microbes Infect."},{"key":"16375_CR18","doi-asserted-by":"publisher","first-page":"34692","DOI":"10.1074\/jbc.M203858200","volume":"277","author":"T Nordstrom","year":"2002","unstructured":"Nordstrom, T., Forsgren, A. & Riesbeck, K. The immunoglobulin D-binding part of the outer membrane protein MID from Moraxella catarrhalis comprises 238 amino acids and a tetrameric structure. J. Biol. Chem. 277, 34692\u201334699 (2002).","journal-title":"J. Biol. Chem."},{"key":"16375_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ijc.24427","volume":"125","author":"KD Preuss","year":"2009","unstructured":"Preuss, K. D. et al. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS. Int. J. Cancer 125, 656\u2013661 (2009).","journal-title":"Int. J. Cancer"},{"key":"16375_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S1470-2045(09)70331-6","volume":"11","author":"S Grass","year":"2010","unstructured":"Grass, S., Preuss, K. D. & Pfreundschuh, M. Autosomal-dominant inheritance of hyperphosphorylated paratarg-7. Lancet Oncol. 11, 12 (2010).","journal-title":"Lancet Oncol."},{"key":"16375_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1172\/JCI76802","volume":"125","author":"KD Preuss","year":"2015","unstructured":"Preuss, K. D., Pfreundschuh, M., Fadle, N., Regitz, E. & Kubuschok, B. Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor. J. Clin. Invest. 125, 316\u2013323 (2015).","journal-title":"J. Clin. Invest."},{"key":"16375_CR22","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1182\/blood-2018-03-836932","volume":"132","author":"L Thurner","year":"2018","unstructured":"Thurner, L. et al. Hyper N-glycosylated SAMD14 and neurabin-I as driver CNS autoantigens of PCNSL. Blood 132, 2744\u20132753 (2018).","journal-title":"Blood"},{"key":"16375_CR23","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1182\/blood-2012-08-447904","volume":"121","author":"C Zwick","year":"2013","unstructured":"Zwick, C. et al. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells. Blood 121, 4708\u20134717 (2013).","journal-title":"Blood"},{"key":"16375_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/PAS.0000000000000107","volume":"38","author":"AR Huppmann","year":"2014","unstructured":"Huppmann, A. R. et al. EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults. Am. J. Surg. Pathol. 38, 316\u2013324 (2014).","journal-title":"Am. J. Surg. Pathol."},{"key":"16375_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R K\u00fcppers","year":"2005","unstructured":"K\u00fcppers, R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5, 251\u2013262 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"16375_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1099\/00222615-46-5-360","volume":"46","author":"MC Enright","year":"1997","unstructured":"Enright, M. C. & McKenzie, H. Moraxella (Branhamella) catarrhalis\u2014clinical and molecular aspects of a rediscovered pathogen. J. Med. Microbiol. 46, 360\u2013371 (1997).","journal-title":"J. Med. Microbiol."},{"key":"16375_CR27","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.4049\/jimmunol.122.4.1468","volume":"122","author":"A Forsgren","year":"1979","unstructured":"Forsgren, A. & Grubb, A. O. Many bacterial species bind human IgD. J. Immunol. 122, 1468\u20131472 (1979).","journal-title":"J. Immunol."},{"key":"16375_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/QCO.0b013e3283298e4e","volume":"22","author":"ML Perez Vidakovics","year":"2009","unstructured":"Perez Vidakovics, M. L. & Riesbeck, K. Virulence mechanisms of Moraxella in the pathogenesis of infection. Curr. Opin. Infect. Dis. 22, 279\u2013285 (2009).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"16375_CR29","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/eji.200535594","volume":"36","author":"M Samuelsson","year":"2006","unstructured":"Samuelsson, M. et al. The IgD CH1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID. Eur. J. Immunol. 36, 2525\u20132534 (2006).","journal-title":"Eur. J. Immunol."},{"key":"16375_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.molimm.2008.07.032","volume":"46","author":"M Seifert","year":"2009","unstructured":"Seifert, M. et al. A model for the development of human IgD-only B cells: genotypic analyses suggest their generation in superantigen driven immune responses. Mol. Immunol. 46, 630\u2013639 (2009).","journal-title":"Mol. Immunol."},{"key":"16375_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMoa013376","volume":"347","author":"O Hermine","year":"2002","unstructured":"Hermine, O. et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347, 89\u201394 (2002).","journal-title":"N. Engl. J. Med."},{"key":"16375_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/path.1984","volume":"209","author":"E Chanudet","year":"2006","unstructured":"Chanudet, E. et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J. Pathol. 209, 344\u2013351 (2006).","journal-title":"J. Pathol."},{"key":"16375_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","volume":"115","author":"VJ Craig","year":"2010","unstructured":"Craig, V. J. et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 115, 581\u2013591 (2010).","journal-title":"Blood"},{"key":"16375_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ijc.29478","volume":"37","author":"F Neumann","year":"2015","unstructured":"Neumann, F. et al. CD4(+) T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenstrom\u2019s macroglobulinemia. Int. J. Cancer 37, 1076\u20131084 (2015).","journal-title":"Int. J. Cancer"},{"key":"16375_CR35","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1182\/blood-2018-10-877761","volume":"16","author":"S Borchmann","year":"2019","unstructured":"Borchmann, S. et al. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood 16, 2121\u20132129 (2019).","journal-title":"Blood"},{"key":"16375_CR36","first-page":"1","volume":"6756","author":"CT Ellebrecht","year":"2016","unstructured":"Ellebrecht, C. T. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science (80-.) 6756, 1\u201311 (2016).","journal-title":"Science (80-.)"},{"key":"16375_CR37","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0140-6736(14)61469-0","volume":"385","author":"K Behringer","year":"2015","unstructured":"Behringer, K. et al. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin\u2019s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. Lancet 385, 1418\u20131427 (2015).","journal-title":"Lancet"},{"key":"16375_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1182\/blood.V116.21.765.765","volume":"116","author":"E A.","year":"2010","unstructured":"A., E. et al. Dose-escalation with BEACOPP escalated is superior to ABVD in the combined-modality treatment of early unfavorable Hodgkin lymphoma: final analysis of the German hodgkin study group (GHSG) HD14 trial. Blood 116, 765 (2010).","journal-title":"Blood"},{"key":"16375_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/hon.2437_52","volume":"35","author":"P Borchmann","year":"2017","unstructured":"Borchmann, P. et al. eBEACOPP with or without Rituximab in Interim-PET-positive advanced-stage Hodgkin Lymphoma: updated results of the international, randomized phase 3 GHSG HD18 Trial. Hematol. Oncol. 35, 65 (2017).","journal-title":"Hematol. Oncol."},{"key":"16375_CR40","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","volume":"390","author":"P Borchmann","year":"2017","unstructured":"Borchmann, P. et al. PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet 390, 2790\u20132802 (2017).","journal-title":"Lancet"},{"key":"16375_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","volume":"9","author":"M Pfreundschuh","year":"2008","unstructured":"Pfreundschuh, M. et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 9, 105\u2013116 (2008).","journal-title":"Lancet Oncol."},{"key":"16375_CR42","doi-asserted-by":"crossref","unstructured":"Schmitz, N. et al. Conventional chemoimmunotherapy (R-CHOEP-14) or high-dose therapy (R-Mega-CHOEP) for young, high-risk patients with aggressive B-cell lymphoma: final results of the randomized Mega-CHOEP trial of the German High-Grade Non-Hodgkin Lymphona Study Group (DSHNL). J. Clin. Oncol. 29,\u00a08002\u20138002 (2011).","DOI":"10.1200\/jco.2011.29.15_suppl.8002"},{"key":"16375_CR43","doi-asserted-by":"publisher","first-page":"7574","DOI":"10.1200\/JCO.2018.36.15_suppl.7574","volume":"36","author":"M Pfreundschuh","year":"2018","unstructured":"Pfreundschuh, M. et al. Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: results of the 2x2 randomized UNFOLDER trial of the DSHNHL\/GLA. J. Clin. Oncol. 36, 7574\u20137574 (2018).","journal-title":"J. Clin. Oncol."},{"key":"16375_CR44","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1182\/blood-2018-99-112403","volume":"132","author":"V Poeschel","year":"2018","unstructured":"Poeschel, V. et al. Excellent outcome of young patients (18\u201360 years) with favourable-prognosis diffuse large B-cell lymphoma (DLBCL) treated with 4 cycles CHOP plus 6 applications of rituximab: results of the 592 patients of the flyer trial of the Dshnhl\/GLA. Blood 132, 781 (2018).","journal-title":"Blood"},{"key":"16375_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-62703-269-8_3","volume":"971","author":"R K\u00fcppers","year":"2013","unstructured":"K\u00fcppers, R., Schneider, M. & Hansmann, M. L. Laser-based microdissection of single cells from tissue sections and PCR analysis of rearranged immunoglobulin genes from isolated normal and malignant human B cells. Methods Mol. Biol. 971, 49\u201363 (2013).","journal-title":"Methods Mol. Biol."},{"key":"16375_CR46","first-page":"S90","volume":"26","author":"J Voswinkel","year":"2008","unstructured":"Voswinkel, J. et al. A novel system to test for specificity of B cell receptors from tissue of Wegener\u2019s granulomatosis patients. Clin. Exp. Rheumatol. 26, S90\u2013S96 (2008).","journal-title":"Clin. Exp. Rheumatol."},{"key":"16375_CR47","doi-asserted-by":"publisher","first-page":"18218","DOI":"10.1074\/jbc.274.26.18218","volume":"274","author":"HJ de Haard","year":"1999","unstructured":"de Haard, H. J. et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 274, 18218\u201318230 (1999).","journal-title":"J. Biol. Chem."},{"key":"16375_CR48","doi-asserted-by":"publisher","first-page":"e64422","DOI":"10.1371\/journal.pone.0064422","volume":"8","author":"M Smidt","year":"2013","unstructured":"Smidt, M. et al. Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model. PLoS ONE 8, e64422 (2013).","journal-title":"PLoS ONE"},{"key":"16375_CR49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41375-018-0182-1","volume":"33","author":"L Thurner","year":"2019","unstructured":"Thurner, L. et al. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting. Leukemia 33, 148\u2013158 (2019).","journal-title":"Leukemia"},{"key":"16375_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gni137","volume":"33","author":"GW Bornkamm","year":"2005","unstructured":"Bornkamm, G. W. et al. Stringent doxycycline-dependent control of gene activities using an episomal one-vector system. Nucleic Acids Res. 33, 1\u201311 (2005).","journal-title":"Nucleic Acids Res."},{"key":"16375_CR51","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/1097-0142(19850215)55:4<683::AID-CNCR2820550402>3.0.CO;2-O","volume":"55","author":"S Poppema","year":"1985","unstructured":"Poppema, S. et al. Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin\u2019s disease. Evidence for a B-cell origin of Sternberg-Reed cells. Cancer 55, 683\u2013690 (1985).","journal-title":"Cancer"},{"key":"16375_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-3-642-83781-4_7","volume":"117","author":"S Poppema","year":"1989","unstructured":"Poppema, S. et al. The typical Reed\u2013Sternberg phenotype and Ig gene rearrangement of Hodgkin\u2019s disease derived cell line ZO indicating a B-cell origin. Recent Results Cancer Res. 117, 67\u201374 (1989).","journal-title":"Recent Results Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16375-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16375-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T06:59:41Z","timestamp":1696143581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16375-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16375"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16375-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"15 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2465"}}